[1] Welberg L. Epigenetics: keeping it in the family[J]. Nat Rev Neurosci, 2013, 14(7):458-459.
[2] Szulwach KE, Jin P. Integrating DNA methylation dynamics into a framework for understanding epigenetic codes[J]. Bioessays, 2014, 36(1):107-117.
[3] Panayiotidis MI. Cancer epigenetics as biomarkers of clinical significance[J]. Cancer Lett, 2014, 342(2):168-169.
[4] Wright R, Saul RA. Epigenetics and primary care[J]. Pediatrics, 2013, 132 Suppl 3:S216-223.
[5] Johnson C, Warmoes MO, Shen X, et al. Epigenetics and cancer metabolism[J]. Cancer Lett, 2013, In press.
[6] Ponomarev I. Epigenetic control of gene expression in the alcoholic brain[J]. Alcohol Res, 2013, 35(1):69-76.
[7] Lawrence J. Interview: from down′s syndrome to basic epigenetics and back again [J]. Epigenomics, 2013, 5(6):611-614.
[8] Zhong X, Zhu Y, Mao J, et al. Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer[J]. J Cancer Res Clin Oncol, 2013, 139(3):485-490.
[9] Zhao Y, Zhou H, Ma K, et al. Abnormal methylation of seven genes and their associations with clinical characteristics in early stage nonsmall cell lung cancer[J]. Oncol Lett, 2013, 5(4):1211-1218.
[10] Yu YP, Ding Y, Chen R, et al. Wholegenome methylation sequencing reveals distinct impact of differential methylations on gene transcription in prostate cancer[J]. Am J Pathol, 2013, 183(6):1960-1970.
[11] 谭双香, 易红, 汤参娥, 等. 鼻咽癌细胞株1433σ启动子去甲基化与基因表达研究[J]. 国际肿瘤学杂志, 2008, 35(4):312-315.
[12] Lan J, Tai HC, Lee SW, et al. Deficiency in expression and epigenetic DNA methylation of ASS1 gene in nasopharyngeal carcinoma: negative prognostic impact and therapeutic relevance[J]. Tumour Biol, 2014, 35(1):161-169.
[13] Yan C, Liu C, Jin Q, et al. The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines [J]. Oncol Lett, 2012, 4(3):505-508.
[14] Kim JG, Park MT, Heo K, et al. Epigenetics meets radiation biology as a new approach in cancer treatment[J]. Int J Mol Sci, 2013, 14(7):15059-15073.
[15] Hofsteeeer B, Niemiertko A, Forrer C, et al. Impact of genomic methylation on radiation sensitivity of colorectal carcinoma[J]. Int J Radiat Oncol Biol Phys, 2010, 76(5):1512-1519.
[16] Karapetyan AR, Buiting C, Kuiper RA, et al. Regulatory roles for long ncRNA and mRNA[J]. Cancers (Basel), 2013, 5(2):462-490.
[17] Liu N, Chen NY, Cui RX, et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis[J]. Lancet Oncol, 2012, 13(6):633-641.
[18] Zhang LY, HoFun Lee V, Wong AM, et al. MicroRNA144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN[J]. Carcinogenesis, 2013, 34(2):454-463.
[19] Zhang Y, Chen X, Ren P, et al. Synergistic effect of combination topotecan and chronomodulated radiation therapy on xenografted human nasopharyngeal carcinoma [J]. Int J Radiat Oncol Biol Phys, 2013, 87(2):356-362.
[20] Li B, Huang G, Zhang X, et al. Increased phosphorylation of histone H3 at serine 10 is involved in EpsteinBarr virus latent membrane protein1induced carcinogenesis of nasopharyngeal carcinoma[J]. BMC Cancer, 2013, 13:124.
[21] 陈济, 刘定义. 表观遗传调控与胃癌[J]. 国际肿瘤学杂志, 2012, 39(4): 292-295.
[22] Ritchie EK, Feldman EJ, Christos PJ, et al. Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia[J]. Leuk Lymphoma, 2013, 54(9):2003-2007. |